| 時間 | 主題 | ||||
|---|---|---|---|---|---|
PD08-1: Can ERBT take place of the importance of traditional TURBt?
講者:
倪雪雰
座長:
楊啟瑞, 李建儀 |
倪雪雰 |
楊啟瑞, 李建儀 |
|||
PD08-2: Treatment outcome and FGFR alteration rate in unresectable locally advanced or metastatic urothelial cancer in Taiwan
講者:
李建儀
座長:
楊啟瑞, 李建儀 |
李建儀 |
楊啟瑞, 李建儀 |
|||
PD08-3: Long non-coding RNA mediates cisplatin and gemcitabine resistance in upper tract urothelial carcinoma cells by sponging of miR-31
講者:
徐偉齊
座長:
楊啟瑞, 李建儀 |
徐偉齊 |
楊啟瑞, 李建儀 |
|||
PD08-4: Partial cystectomy after neoadjuvant chemotherapy for muscle invasive bladder cancer
講者:
楊啟瑞
座長:
楊啟瑞, 李建儀 |
楊啟瑞 |
楊啟瑞, 李建儀 |
|||
PD08-5: miR-375 suppresses upper tract urothelial carcinoma cell migration and invasion via targeting Derlin-1
講者:
詹鎮豪
座長:
楊啟瑞, 李建儀 |
詹鎮豪 |
楊啟瑞, 李建儀 |
|||
PD08-6: Immune checkpoint biomarker on circulating tumor cells as a potential predictor of therapeutic efficacy in urothelial carcinoma patients
講者:
賴姿君
座長:
楊啟瑞, 李建儀 |
賴姿君 |
楊啟瑞, 李建儀 |